Shilpa CDMO invests $50 million to expand peptide manufacturing capacity

Shilpa CDMO is investing $50 million to expand its peptide manufacturing capabilities as demand for GLP-1s and peptide therapeutics

By Maren Holt · Senior Reporter, GLP-1

Nov 4 01:45 ETSource: Express Pharma

From the source

Shilpa CDMO invests $50 million to expand peptide manufacturing capacity
Shilpa CDMO is investing $50 million to expand its peptide manufacturing capabilities as demand for GLP-1s and peptide therapeutics increases.

Read at expresspharma.in

Source URL https://www.expresspharma.in/amp/shilpa-cdmo-invests-50-million-to-expand-peptide-manufacturing-capacity/